Autophagy, a novel target for chemotherapeutic intervention of thyroid cancer

Cancer Chemotherapy and Pharmacology

Volumn 73, Issue 3, 2014, Pages 439-449

  Li, Le Chen ^a   Liu, Guo Dong ^a   Zhang, Xin Jie ^a   Li, Yan Bo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Chemotherapy; miRNA; p53; Thyroid cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BECLIN 1; DOXORUBICIN; EVEROLIMUS; MICRORNA; ROSUVASTATIN; SELUMETINIB; SORAFENIB; SUNITINIB; TUMOR SUPPRESSOR PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESEARCH; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CHEMOSENSITIVITY; HUMAN; MACROAUTOPHAGY; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; THYROID CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; HUMANS; THYROID NEOPLASMS;

EID: 84896028278     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2363-y     Document Type: Review

References (99)

1. Miniño AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59:1-126
2. Sipos JA, Mazzaferri EL (2010) Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 22:395-404. doi:10.1016/j.clon.2010.05. 004
3. Kilfoy BA, Zheng T, Holford TR, Han X (2009) International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20:525-531. doi:10.1007/s10552-008-9260-4
4. Mizushima N (2007) Autophagy: process and function. Genes Dev 21:2861-2873
5. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674. doi:10.1016/j
6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83:2638-2648 (Pubitemid 29019586)
7. Matuszczyk A, Petersen S, Bockisch A, Gorges R, Sheu SY, Veit P, Mann K (2008) Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium. Horm Metab Res 40:210-213. doi:10.1055/s-2008-1046781 (Pubitemid 351690526)
8. Lin CI, Whang EE, Abramson MA, Jiang X, Price BD, Donner DB, Moore FD Jr, Ruan DT (2009) Autophagy: a new target for advanced papillary thyroid cancer therapy. Surgery 146:1208-1214. doi:10.1016/j.surg.2009.09.019
9. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
10. Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 79:564-573 (Pubitemid 27051783)
11. Leboulleux S, Baudin E, Travagli JP, Schlumberger M (2004) Medullary thyroid carcinoma. Clin Endocrinol 61:299-310 (Pubitemid 39287058)
12. Buytaert E, Callewaert G, Vandenheede JR, Agostinis P (2006) Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2:238-240 (Pubitemid 44030895)
13. Yeung S-CJ, She M, Yang H, Pan J, Sun L, Chaplin D (2007) Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model. J Clin Endocrinol Metab 92:2902-2909 (Pubitemid 47236348)
14. Codogno P, Meijer AJ (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12(Suppl 2):1509-1518 (Pubitemid 41553987)
15. Agarwala SS, Case S (2010) Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: a review. Oncologist 15:236-245. doi:10.1634/theoncologist.2009-0141
16. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B, Vande Woude GF (1997) Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 94:11445-11450 (Pubitemid 27451018)
17. Abraham D, Jackson N, Gundara JS, Zhao J, Gill AJ, Delbridge L, Robinson BG, Sidhu SB (2011) MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 17:4772-4781. doi:10.1158/1078-0432.CCR-11-0242
18. Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, Qin Y, Sun Z, Zheng X (2010) miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10:354. doi:10.1186/1471-2407-10-354
19. Wang G, Mao W, Zheng S (2008) MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582:3663-3668. doi:10.1016/j.febslet.2008.09.051
20. Anastasia L, Pelissero G, Venerando B, Tettamanti G (2010) Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Cell Death Differ 17:1230-1237. doi:10.1038/cdd.2010. 14
21. Jemaà M, Galluzzi L, Kepp O, Boilève A, Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia A, Castedo M, Vitale I, Kroemer G (2012) Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle 11:2149-2158. doi:10.4161/cc.20621
22. Nikiforov YE (2004) Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 15:319-327
23. Lee YR, Wu WC, Ji WT, Chen JY, Cheng YP, Chiang MK, Chen HR (2012) Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy. J Biomed Sci 19:9. doi:10.1186/1423-0127- 19-9
24. Hua SC, Chang TC, Chen HR, Lu CH, Liu YW, Chen SH, Yu HI, Chang YP, Lee YR (2012) Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells. Pharm Res 29:1990-2005. doi:10.1007/s11095-012-0727-3
25. D'Alise AM, Amabile G, Iovino M, Di Giorgio FP, Bartiromo M, Sessa F, Villa F, Musacchio A, Cortese R (2008) Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Mol Cancer Ther 7:1140-1149. doi:10.1158/1535-7163.MCT-07-2051
26. McMillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, Griffin JD, Richardson PG, Anderson KC, Mitsiades CS (2010) Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med 16:483-489. doi:10.1038/nm.2112
27. Lu C-H, Liu Y-W, Hua S-C, Yu H-I, Chang Y-P, Lee Y-R (2012) Autophagy induction of reversine on human follicular thyroid cancer cells. Biomed Pharmacother 66:642-647. doi:10.1016/j.biopha.2012.08.001
28. Lin C-I, Whang EE, Lorch JH, Ruan DT (2012) Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer. Surgery 152:1142-1149. doi:10.1016/j.surg.2012.08.016
29. Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682-687 (Pubitemid 351398539)
30. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, Ezaki J, Mizushima N, Ohsumi Y, Uchiyama Y, Kominami E, Tanaka K, Chiba T (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169:425-434 (Pubitemid 40686693)
31. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, Lippincott-Schwartz J (2010) Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141:656-667. doi:10.1016/j.cell.2010.04.009
32. Mizushima N, Levine B (2010) Autophagy in mammalian development and differentiation. Nat Cell Biol 12(9):823-830. doi:10.1038/ncb0910-823
33. White E, Karp C, Strohecker AM, Guo Y, Mathew R (2010) Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 22:212-217. doi:10.1016/j.ceb.2009.12.008
34. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67-93. doi:10.1146/annurev-genet-102808-114910
35. Barth S, Glick D, Macleod KF (2010) Autophagy: assays and artifacts. J Pathol 221:117-124. doi:10.1002/path.2694
36. Lum JJ, DeBerardinis RJ, Thompson CB (2005) Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6:439-448 (Pubitemid 40780556)
37. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC (2004) Inhibition of mTOR induces autophagy and reduces toxicity of poly glutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36:585-595 (Pubitemid 38715985)
38. Kanazawa T, Taneike I, Akaishi R, Yoshizawa F, Furuya N, Fujimura S, Kadowaki M (2004) Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem 279:8452-8459 (Pubitemid 38294738)
39. Suzuki K, Ohsumi Y (2007) Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 581:2156-2161 (Pubitemid 46709906)
40. Das G, Shravage BV, Baehrecke EH (2012) Regulation and function of autophagy during cell survival and cell death. Cold Spring Harb Perspect Biol 4(6). doi:10.1101/cshperspect.a008813
41. Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11:709-730. doi:10.1038/nrd3802
42. Rouschop KM, Wouters BG (2009) Regulation of autophagy through multiple independent hypoxic signaling pathways. Curr Mol Med 9:417-424
43. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654-666. doi:10.1158/1078-0432.CCR-10-2634
44. White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15:5308-5316. doi:10.1158/1078-0432.CCR-07-5023
45. Chen N, Karantza-Wadsworth V (2009) Role and regulation of autophagy in cancer. Biochim Biophys Acta 1793:1516-1523. doi:10.1016/j.bbamcr.2008.12.013
46. Chen S, Rehman SK, Zhang W, Wen A, Yao L, Zhang J (2010) Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta 1806:220-229. doi:10.1016/j.bbcan.2010.07.003
47. Gozuacik D, Kimchi A (2007) Autophagy and cell death. Curr Top Dev Biol 78:217-245
48. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:121-134 (Pubitemid 44040988)
49. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927-939 (Pubitemid 41345209)
50. Feng W, Huang S, Wu H, Zhang M (2007) Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin 1. J Mol Biol 372:223-235 (Pubitemid 47223231)
51. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi K (2008) Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68:7966-7974. doi:10.1158/0008-5472.CAN-08-1333
52. Muñoz-Gámez JA, Rodríguez-Vargas JM, Quiles-Pérez R, Aguilar-Quesada R, Martín-Oliva D, de Murcia G, Menissier de Murcia J, Almendros A, Ruiz de Almodóvar M, Oliver FJ (2009) PARP-1 is involved in autophagy induced by DNA damage. Autophagy 5:61-74
53. Easton JB, Houghton PJ (2006) mTOR and cancer therapy. Oncogene 25:6436-6446 (Pubitemid 44582287)
54. Johnson BE, Jackman D, Janne PA (2007) Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer. Clin Cancer Res 13:s4628-s4631
55. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34:1069-1075
56. Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, Laine E, Greulich H, Tseng H, Gates C, Hodi FS, Dranoff G, Sellers WR, Thomas RK, Meyerson M, Golub TR, Dummer R, Herlyn M, Getz G, Garraway LA (2008) Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 68:664-673. doi:10.1158/0008-5472.CAN-07-2615 (Pubitemid 351206741)
57. Wang G, Mao W, Zheng S (2008) MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582:3663-3668. doi:10.1016/j.febslet.2008.09.051
58. Nakahara S, Oka N, Raz A (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10:267-275 (Pubitemid 40603482)
59. Idikio HA (2011) Galectin-3 and beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkers. PLoS ONE 6:e26150. doi:10.1371/journal.pone.0026150
60. Mizushima N (2005) The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ 12(Suppl 2):1535-1541
61. Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH, Chen CC (2008) Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res 68:2375-2383. doi:10.1158/0008-5472.CAN- 07-5807
62. Sassano A, Platanias LC (2008) Statins in tumor suppression. Cancer Lett 260:11-19. doi:10.1016/j.canlet.2007.11.036
63. Zeybek ND, Gulcelik NE, Kaymaz FF, Sarisozen C, Vural I, Bodur E, Canpinar H, Usman A, Asan E (2011) Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells. J Endocrinol 210:105-115. doi:10.1530/JOE-10-0411
64. Scott RC, Juhász G, Neufeld TP (2007) Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Curr Biol 17:1-11 (Pubitemid 46027564)
65. Tsujimoto Y, Shimizu S (2005) Another way to die: autophagic programmed cell death. Cell Death Differ 12(Suppl 2):1528-1534 (Pubitemid 41553989)
66. Thorburn A (2008) Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13:1-9
67. Shi M, Zhang T, Sun L, Luo Y, Liu DH, Xie ST, Song XY, Wang GF, Chen XL, Zhou BC, Zhang YZ (2013) Calpain, Atg5 and Bak play important roles in the crosstalk between apoptosis and autophagy induced by influx of extracellular calcium. Apoptosis 18:435-451. doi:10.1007/s10495-012-0786-2
68. Sarbassov DD, Ali SM, Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17:596-603 (Pubitemid 41540408)
69. Corcelle EA, Puustinen P, Jaattela M (2009) Apoptosis and autophagy: targeting autophagy signalling in cancer cells - 'trick or treats'? FEBS J 276:6084-6096. doi:10.1111/j.1742-4658.2009.07332.x
70. Chan EY, Kir S, Tooze SA (2007) siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J Biol Chem 282:25464-25474 (Pubitemid 47372826)
71. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67-93
72. Zou CF, Jia L, Jin H, Yao M, Zhao N, Huan J, Lu Z, Bast RC Jr, Feng Y, Yu Y (2011) Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer 11:22. doi:10.1186/1471-2407-11-22
73. Eum KH, Lee M (2011) Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts. Mol Cell Biochem 348:61-68. doi:10.1007/s11010-010-0638-8
74. Yang PM, Chen CC (2011) Life or death? Autophagy in anticancer therapies with statins and histone deacetylase inhibitors. Autophagy 7:107-108
75. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674. doi:10.1016/j.cell.2011.02.013
76. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741-752 (Pubitemid 47312826)
77. Platini F, Perez-Tomas R, Ambrosio S, Tessitore L (2010) Understanding autophagy in cell death control. Curr Pharm Des 16:101-113
78. Yue Z, Jin S, Yang C, Levine AJ, Heintz N (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100:15077-15082 (Pubitemid 37518019)
79. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, Mizushima N (2011) Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25:795-800. doi:10.1101/gad.2016211
80. Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I, Mannucci S, Biagioli M, Toscano M, Moretti D, Lio R, Massi D (2010) Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 41:503-512. doi:10.1016/j.humpath.2009.09.004
81. Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11:709-730. doi:10.1038/nrd3802
82. Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Reichelt J, Levine B (2012) Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338:956-959. doi:10.1126/science.122596
83. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, White E (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367-1381 (Pubitemid 46871040)
84. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, White E (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137:1062-1075. doi:10.1016/j.cell.2009.03.048
85. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, Nelson DA, Jin S, White E (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10:51-64
86. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401-410. doi:10.1038/nrc3262
87. Kenific CM, Thorburn A, Debnath J (2010) Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol 22:241-245. doi:10.1016/j.ceb. 2009.10.008
88. Horbinski C, Mojesky C, Kyprianou N (2010) Live free or die: tales of homeless (cells) in cancer. Am J Pathol 177:1044-1052. doi:10.2353/ajpath.2010. 091270
89. He C, Levine B (2010) The Beclin 1 interactome. Curr Opin Cell Biol 22:140-149. doi:10.1016/j.ceb.2010.01.001
90. Liu B, Cheng Y, Liu Q, Bao JK, Yang JM (2010) Autophagic pathways as new targets for cancer drug development. Acta Pharmacol Sin 31:1154-1164. doi:10.1038/aps.2010.118
91. Budanov AV, Karin M (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134:451-460. doi:10.1016/j.cell.2008. 06.028
92. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, Nannmark U, Samara C, Pinton P, Vicencio JM, Carnuccio R, Moll UM, Madeo F, Paterlini-Brechot P, Rizzuto R, Szabadkai G, Pierron G, Blomgren K, Tavernarakis N, Codogno P, Cecconi F, Kroemer G (2008) Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10:676-687. doi:10.1038/ncb1730 (Pubitemid 351772933)
93. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G (2009) Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 1793:1524-1532. doi:10.1016/j.bbamcr.2009.01.006
94. Cosse JP, Rommelaere G, Ninane N, Arnould T, Michiels C (2010) BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway. Biochem Pharmacol 80:1160-1169. doi:10.1016/j.bcp.2010.07.009
95. Lee SB, Tong SY, Kim JJ, Um SJ, Park JS (2007) Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells DNA. Cell Biol 26:713-720
96. Sun Y, Zhang J, Peng ZL (2009) Beclin1 induces autophagy and its potential contributions to sensitizes SiHa cells to carboplatin therapy. Int J Gynecol Cancer 19:772-776. doi:10.1111/IGC.0b013e31819d7d10
97. Mukubou H, Tsujimura T, Sasaki R, Ku Y (2010) The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol 37:821-828
98. Shingu T, Fujiwara K, Bögler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, Kondo S (2009) Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity. Autophagy 5:537-539
99. Feng Z (2010) p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol 2:a001057. doi:10.1101/cshperspect.a001057